Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.


Chegou, NN; Sutherland, JS; Malherbe, S; Crampin, AC; Corstjens, PL; Geluk, A; Mayanja-Kizza, H; Loxton, AG; van der Spuy, G; Stanley, K; Kotzé, LA; van der Vyver, M; Rosenkrands, I; Kidd, M; van Helden, PD; Dockrell, HM; Ottenhoff, TH; Kaufmann, SH; Walzl, G; AE-TBC consortium, ; , COLLABORATORS; Kriel, M; Malherbe, S; Kriel, B; Awoniyi, DO; Maasdorp, E; Owolabi, O; Sillah, A; Mendy, J; Gindeh, A; Donkor, S; Togun, T; Ota, M; Simukonda, F; Amberbir, A; Chilongo, F; Houben, R; Kassa, D; Gebrezgeabher, A; Mesfin, G; Belay, Y; Gebremichael, G; Alemayehu, Y; Amutenya, FN; Nelongo, JN; Monye, L; Sheehama, JA; Iipinge, S; Namuganga, AR; Muzanye, G; Nsereko, M; Peters, P; Howe, R; Mihret, A; Bekele, Y; Tessema, B; Yamuah, L; Ottenhoff, TH; Franken, KL; Corstjens, PL; Fat, EM; de Dood, CJ; van der Ploeg-van Schip, JJ; Aagaard, C; Kaufmann, SH; Esterhuyse, MM; Cliff, JM; (2016) Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB. Thorax, 71 (9). pp. 785-94. ISSN 0040-6376 DOI: 10.1136/thoraxjnl-2015-207999

This is the latest version of this item. Earlier version may have full text manuscript

Full text not available from this repository. (Request a copy)

Abstract

: User-friendly, rapid, inexpensive yet accurate TB diagnostic tools are urgently needed at points of care in resource-limited settings. We investigated host biomarkers detected in serum samples obtained from adults with signs and symptoms suggestive of TB at primary healthcare clinics in five African countries (Malawi, Namibia, South Africa, The Gambia and Uganda), for the diagnosis of TB disease.<br/> : We prospectively enrolled individuals presenting with symptoms warranting investigation for pulmonary TB, prior to assessment for TB disease. We evaluated 22 host protein biomarkers in stored serum samples using a multiplex cytokine platform. Using a pre-established diagnostic algorithm comprising of laboratory, clinical and radiological findings, participants were classified as either definite TB, probable TB, questionable TB status or non-pulmonary TB.<br/> : Of the 716 participants enrolled, 185 were definite and 29 were probable TB cases, 6 had questionable TB disease status, whereas 487 had no evidence of TB. A seven-marker biosignature of C reactive protein, transthyretin, IFN-γ, complement factor H, apolipoprotein-A1, inducible protein 10 and serum amyloid A identified on a training sample set (n=491), diagnosed TB disease in the test set (n=210) with sensitivity of 93.8% (95% CI 84.0% to 98.0%), specificity of 73.3% (95% CI 65.2% to 80.1%), and positive and negative predictive values of 60.6% (95% CI 50.3% to 70.1%) and 96.4% (95% CI 90.5% to 98.8%), respectively, regardless of HIV infection status or study site.<br/> : We have identified a seven-marker host serum protein biosignature for the diagnosis of TB disease irrespective of HIV infection status or ethnicity in Africa. These results hold promise for the development of a field-friendly point-of-care screening test for pulmonary TB.<br/>

Item Type: Article
Faculty and Department: Academic Services & Administration > Academic Administration
Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
Faculty of Infectious and Tropical Diseases > Dept of Immunology and Infection
Research Centre: TB Centre
MEIRU
PubMed ID: 27146200
URI: http://researchonline.lshtm.ac.uk/id/eprint/2569436

Available Versions of this Item

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
109Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item